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Abstract Distraction osteogenesis can be used to replace
segmental bone loss when treating malignant bone tumors in
children and adolescents. These patients often receive cyto-
toxic chemotherapy as part of their treatment regimen. The
effect of cytotoxic drugs on the cellular processes during
distraction osteogenesis and the structural and mechanical
properties of regenerate bone is unknown. We therefore used
a rabbit model of distraction osteogenesis to determine that
cytotoxic agents had a detrimental effect on regenerate bone
formed by this technique. We administered adriamycin and
cisplatinum to 20 rabbits using two different simulated che-
motherapy regimens. All rabbits underwent an osteotomy at
12 weeks of age. Distraction osteogenesis began 24 h later at
a rate of 0.75 mm a day for 10 days, followed by 18 days
without correction to allow for consolidation. Regenerate
bone was assessed using plain radiographs, bone densitom-
etry, and mechanical testing. Peri-operative chemotherapy
decreased the mechanical properties of the regenerate with
regard to yield strain (3.7 9 10-2 vs. 5.2 9 10-2) and energy
at yield (2.73 9 107 vs. 3.92 9 107). Preoperative chemo-
therapy in isolation reduced bone mineral density (0.38 vs.
0.5 g/cm2), bone mineral content (0.24 vs. 0.36 g), and vol-
umetric bone mineral density (0.57 vs. 0.65 g/cm2) with no
alterations in the mechanical properties. Conclusions: Pre-
operative chemotherapy appears to decrease the volume of
regenerate bone, without affecting structural integrity, sug-
gesting that the callus formed is of good quality. The converse
appears true for peri-operative chemotherapy.
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Introduction
The treatment of malignant bone tumors in children and ado-
lescents has improved over the last four decades as a result of
progress in many disciplines. The development of potent
cytotoxic agents has been of fundamental importance and
initially involved a multiagent approach [8, 17, 27, 28]. Sub-
sequently, a regimen using only two agents (adriamycin and
cisplatinum) not only produced equivalent 15-year disease-
free survival (DFS) and overall survival (OS) [4, 35], but that
there was also only a 9 % rate of local recurrence [34]. This
decreased rate of local recurrence has allowed limb-sparing
surgery to be used more frequently after tumor excision.
The use of endoprostheses in the reconstruction of the
distal femur has been reported to give good or excellent
functional results in 83 % of patients, with a 10 year
survivorship of 77 % [3, 26]. Even in patients with sub-
stantial growth remaining, expandable and adjustable
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prostheses have shown satisfactory functional outcomes in
71 % of patients, assessed using the American Musculo-
skeletal Tumor Society (AMSTS) functional rating system
[6, 10, 32].
Reconstruction using extensive allograft has also been
described for treating osteogenic and Ewing’s sarcoma but
is associated with 77 % complication rate (other than a
limb-length discrepancy) and 54 % rate of allograft frac-
ture [1, 20]. Reconstruction with microvascular-free fibular
grafts has also been reported with decreased fatigue frac-
ture and nonunion compared to allograft and an AMSTS of
good or excellent in 85 % of patients [11, 23, 33].
Distraction osteogenesis is a surgical technique some-
times used to regenerate bone, equalize limb lengths, and
replace segmental bone loss [5, 12–15]. Tsuchiya et al. [37]
also reported a decreased external fixation index (34 days/
cm vs. 40 days/cm) and good or excellent functional results
in 89 % of patients when using this technique compared to
bone transport when reconstructing extensive defects
(average 8.4 cm) after excising skeletal tumors [36]. Dis-
traction osteogenesis relies on the ability of the body to
generate enough bone to not only fill the defect left by
tumor excision, but also to be robust enough to allow the
individual to weight bear. Any interruption to these cellular
processes could have a detrimental effect on new bone
formation, which in turn could lead to failure through the
regenerate bone. To date, we do not know the effect of a
multiagent chemotherapy regimen on these processes, and
this study was designed to address the deficiencies in the
literature.
The questions we aimed to address in our study were as
follows:
1. Do cytotoxic agents affect the structural properties of
new bone formed by distraction osteogenesis?
2. Do cytotoxic agents affect the mechanical integrity of
regenerate bone?
3. Does the timing of chemotherapy influences this
affect?
Materials and methods
Forty rabbits were divided equally and assigned on a ran-
dom basis into two groups. Preoperative cycles of cisplat-
inum and adriamycin were used to simulate the clinical
protocols reported by Malawer et al. [19] and pre- and
postoperative cycles to simulate the cytotoxic regimen used
by the European Osteosarcoma Intergroup [4, 35].
In the preoperative chemotherapy group, cisplatinum
and adriamycin were administered in combination at
8 weeks of age, with a second infusion 14 days later at
10 weeks of age.
In the postoperative group, cisplatinum and adriamycin
were administered in combination 10 days prior to and
4 days after the osteotomy, in order to standardize the
interval between infusions at 14 days.
In both groups, the infusion was either an initial 1 mg/
kg cisplatinum and 2 mg/kg adriamycin followed by a
second infusion of 1 mg/kg cisplatinum and 4 mg/kg
adriamycin or an identical volume of normal saline at
identical points (Fig. 1).
We did not perform a priori power analysis as the
literature was deficient, and no relevant data were avail-
able. This study should be regarded as a pilot and has
generated an hypothesis that will form the basis of further
research.
For all surgical procedures, animals were premedi-
cated 30 min before with 10 mg/kg intramuscular keta-
mine (Parnell Laboratories Australia Pty Ltd,
Alexandria, New South Wales, Australia), 4 mg/kg of
xylazine (Ilium Xylazil-20; Troy Laboratories Pty Ltd,
Smithfield, New South Wales, Australia), and 0.05 mg/
kg of buprenorphine (Reckitt & Coleman Products Ltd,
Hull, UK). General anesthesia was induced through a
face mask using an enflurane (Abbott Australia Pty Ltd
Botany, New South Wales, Australia) and a nitrous
oxide/oxygen mixture. After each anesthetic, the animal
was observed until alert and drinking before being
returned to its cage.
Through an incision in the right groin, a 20-gauge
intravenous cannula (Terumo Corporation, Tokyo, Japan)
was inserted into the femoral vein and secured between two
silk sutures providing a watertight seal. About 50 mL
adriamycin/cisplatinum (intervention) or 50 mL normal
saline (control) was infused over 2 h using an IVAC
syringe pump (ALARIS Medical Systems Australia, Pty
Ltd Seven Hills, New South Wales, Australia). Two weeks
later, a second infusion was administered using an identical
approach through the left femoral vein.
The tibial osteotomy was performed at 12 weeks of age
in an attempt to reproduce the stage of skeletal develop-
ment equivalent to a human adolescent [16]. The right leg
was shaved and prepared with chlorhexidine. A medial
longitudinal skin incision was used with subperiosteal
exposure of the tibia along its length. Three-millimeter
external fixator pins (Orthofix, Bussolengo, Italy) were
inserted 1.5 cm proximal and distal to the midtibial
diaphysis using a standard jig and power drill. We deter-
mined the positions of the remaining two pins using the jig
to create a standard configuration of pins accurately aligned
along the length of the tibia. An M100 monolateral fixator
(Orthofix) was then secured approximately 1.5 cm from the
skin to accommodate for postoperative swelling. The
osteotomy was performed by predrilling the diaphysis and
completing the osteotomy with bone cutters.
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The wound was then closed with interrupted sutures
(Fig. 2) and dressed with povidone-iodine ointment (Pro-
fessional Disposables Inc, Orangeburg, NY, USA).
Distraction osteogenesis began 24 h after surgery. The
fixator was distracted by a half turn every 12 h for 10 days,
followed by a period of 18 days to allow the consolidation
of the regenerate.
Animals in both arms of the study were euthanized. At
16 weeks of age, the right hind limb was disarticulated and
aligned to produce consistent craniocaudal and mediolat-
eral images with a Siemens (Erlangen, Germany) Multix
H/UPH configuration with a focus to film distance of
100 cm and a 50-kV (±2 mV) and 4-mA exposure
(Fig. 3). A single observer (FPM) assessed regenerate
length, AP, and lateral alignment on the orthogonal images.
Bone density measurements were made using a total
body dual-energy X-ray densitometer (DXA; LUNAR
DPX; LUNAR Radiation Corp, Madison, WI, USA) and
software designed for measuring small animals (LUNAR
DPX, Small Animal Software Version 1.0; LUNAR
Radiation Corp). The distance from the knee to the top of
the callus and the height of the callus were measured and
recorded. Each scan produced values for bone mineral
density (BMD), bone mineral content (BMC), and volu-
metric bone mineral density (vBMD).vBMD was calcu-
lated assuming that the bone is an elliptical cylinder.
The area of the cross - section of bone
¼ p  ðAP Bone WidthÞ
2
 (Lat Bone Width)
2
:
The volume of the region V = Cross-sectional Bone
Area 9 ROI Height
Volumetric BMDðg=cm3Þ ¼ BMC
V
The tibiofibular complex was embedded in the mounting
block and placed in an Instron mechanical testing machine
(Instron Corporation, Norwood, MA, USA). Similar to
comparable studies [18], the tibia was loaded in
compression to failure at a rate of 2 mm/min using a 10-kN
Fig. 1 Illustration showing the
chemotherapy regimens used
Fig. 2 Orthofix M 100 External fixator in situ after middiaphyseal
tibial osteotomy
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load cell. The length of exposed bone (lo) was measured
before compression testing. This was standardized during
mounting, ensuring that the polyester resin covered
the screw holes adjacent to the regenerate. It was
assumed that the regenerate was elliptical, and the mean
area was calculated from DXA measurements. The load/
displacement data were transformed to produce stress/





The data were transferred to Easy Plot (Spiral Software,
Maryland, USA), and stress strain curves were produced
for each specimen.
After mechanical testing, the regenerates were decalci-
fied and stained with hematoxylin and eosin. One assessor
(JRB) ( ) blinded to the identity of each specimen was used
to undertake histological examination of each slide
(Fig. 4a, b). Cortical thickening was assessed by taking [3]
separate measurements from the endosteal to the periosteal
surface of the regenerate bone, and the mean thickness was
calculated for each specimen and used for comparison.
Modularization was determined by the trabecular bone
volume. This is the relative volume of total cancellous
bone occupied by trabeculae, expressed as a percentage
[25]. A Shapiro–Wilk test was used to confirm data pro-
duced by mechanical testing, and DEXA analysis was
normally distributed, before an unpaired t test was used.
The two-sided statistic with a 95 % confidence interval was
used in each case.
For histological analysis, a Mann–Whitney U test was
used to compare the histological parameters between
intervention and control groups.
Results
Structurally, preoperative chemotherapy had a detrimental
effect on BMD (p \ 0.01), BMC (p = 0.02), and vBMD
(p = 0.04; Table 1, data produced by DEXA analysis)
compared with a control population.
We observed a reduction (p = 0.97) in the modulus of
elasticity from 5.47 to 5.15 (9103), which would be
expected, because the modulus/stiffness is dependent on
the degree of mineralization (Table 2).
There was no difference in BMD, BMC, or vBMD in the
peri-operative group compared with the control. Histolog-
ically, there was a trend for decreased cortical thickness in
both chemotherapy groups compared with control popula-
tions, but these data were not statistically significant
(p = 0.06 and 0.12; Table 3, data produced by histological
assessment).
With regard to mechanical properties, there was a major
difference in the average yield strain and energy at yield of
the peri-operative group when compared to the control
population (Table 2, data produced by mechanical testing).
Discussion
The aim of this study was to investigate the effects of
multiagent cytotoxic agents on both the mechanical and
structural properties of regenerate bone formed by dis-
traction osteogenesis in a rabbit model. The clinical rele-
vance of this work was to highlight the concerns with
reconstruction of segmental defects after malignant bone
tumor excision by distraction osteogenesis in the presence
of cytotoxic chemotherapy. But the limitations of the study
are clear and direct comparisons should not be made.
Interpretation of the clinical relevance of this work
requires an analysis of the effect on the material and
mechanical characteristics of the regenerate bone. The clini-
cal issue is whether observed differences matter and are of
sufficient concern to prevent reconstruction by this method.
Readers should be aware of the limitations of our study.
First, the group sizes proved to be barely adequate to allow
robust statistical analysis of the mechanical parameters,
and future work should focus on a single specific area with
Fig. 3 a Lateral and b AP radiographs of the tibia after removal of
the fixator. Note the elliptical callus formation, the limb alignment,
and the distance between the osteotomy and the pin sites
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a larger number of animal pairs. Second, we used plain
radiographs to assess the morphology of the regenerate and
determine the alignment of the lengthened bone in two
orthogonal (AP and lateral) planes; however, the accuracy
of plain radiographs is limited. Third, DXA does not
account for the spatial distribution and inherent material
properties of the tissues. While DXA has been used in
similar studies 18, alternative methods of assessment
include peripheral quantified CT (pQCT) and single photon
emission CT. pQCT would have offered a potentially
superior method of assessment [21, 22] and should be
considered as a method of assessment in future work.
Fourth, the regimen chosen was rudimentary when com-
pared to current multiagent regimens used in clinical
practice. The purpose of this study was to investigate the
effects of cytotoxic agents on osteogenesis in general and
not the efficacy of a specific regimen.
Fig. 4 a Hematoxylin and eosin stain (original magnification, 9 4)
showing consolidated regenerate bone at the tibial osteotomy site
after distraction. b Hematoxylin and eosin (original
magnification, 9 10) showing medullary/regenerate interface show-
ing partial modularization of the regenerate bone
Table 1 Data obtained from DXA
Pre-operative group Peri-operative group
Mean value of BMC (g)
Intervention 0.24 0.23
Control 0.36 0.22
p value 0.02 0.79
Mean value of BMD (g/cm2)
Intervention 0.38 0.4
Control 0.5 0.4
p value \0.01 0.97
Mean value of vBMD (g/cm3)
Intervention 0.57 0.67
Control 0.65 0.63
p value 0.04 0.34
Table 2 Data obtained from mehanical testing
Pre-operative group Peri-operative group
Mean modulus of elasticity (Pa)
Intervention 5.88 9 108 5.65 9 108
Control 5.92 9 108 4.62 9 108
p value 0.97 0.32
Mean energy at yield
Intervention 2.45 9 107 2.73 9 107
Control 3.14 9 107 3.92 9 107
p value 0.31 0.01
Mean yield stress
Intervention 1.64 9 107 1.68 9 107
Control 1.63 9 107 1.89 9 107
p value 0.94 0.39
Mean yield strain
Intervention 3.2 9 10-2 3.7 9 10-2
Control 3.7 9 10-2 5.2 9 10-2
p value 0.44 0.01
Mean energy at failure
Intervention 4.92 9 107 5.25 9 107
Control 5.48 9 107 6.41 9 107
p value 0.59 0.27
Mean failure stress
Intervention 1.95 9 107 1.89 9 107
Control 1.87 9 107 1.98 9 10
p value 0.71 0.67
Mean failure strain
Intervention 4.7 9 10-2 5.2 9 10-2
Control 5.4 9 10-2 6.4 9 10-2
p value 0.41 0.11
Mean postyield energy
Intervention 5.63 9 107 2.51 9 107
Control 2.34 9 107 2.48 9 107
p value 0.31 0.97
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Decrease in weight has been identified in previous ani-
mal studies as an indicator of cytotoxic effect [38]. This
effect is also seen in human clinical practice and is the
result of several factors, including anorexia and a catabolic
response to cytotoxic drugs. We demonstrated this differ-
ence in each experimental group, suggesting that the ani-
mals received clinically relevant amounts of cisplatinum
and adriamycin. It was not possible to quantify the mech-
anism leading to this observation, because food and water
were given ad libitum.
There were major differences noted in BMC, BMD, and
vBMD with reduction in the preoperative chemotherapy
group. This observation was likely to be a real effect and
contradicts previous work [7] that did not demonstrate an
alteration in DXA parameters after cisplatinum infusion. A
possible explanation is that the addition of adriamycin has
produced a more profound effect on regenerate minerali-
zation, but more detailed comment is not possible from the
data produced.
Failure occurs on the compression side of an eccentri-
cally loaded bone, leading to progressive bending of
regenerate, which is observed in clinical practice. This
mode of failure is simulated by axial compression, which
was considered most representative of the in vivo mode of
failure. Previous studies [2, 24] have demonstrated a rela-
tionship between structural and mechanical properties of
bone with this type of compression testing, and a simple
uniaxial loading test provided a reproducible method of
analysis for this experiment.
The experiment required reproducible longitudinal
alignment of the bone during compression testing, and this
was achieved using a mounting block. The mounting block
consisted of two cylinders with an adjustable connector to
accommodate variable bone lengths.
The lack of effect on the structural properties of
regenerate is in agreement with Gravel et al. [9], even with
the addition of cisplatinum.
The mechanism in which adriamycin and cisplatinum
affect regenerate mineralization is not clear. The formation
of regenerate bone involves a sequence of events, including
neoangiogenesis [29], chondrocyte differentiation with
expression of bone matrix proteins [31], and collagen I
formation [39]. Adriamycin causes structural alterations in
normal bone with reduction in cortical thickness, histo-
logical changes within the physeal plate, marrow hypo-
plasia [40], and specifically inhibits prolyl hydroxylation,
leading to loss of stability of procollagen [30]. Cisplatinum
causes histomorphometric changes in bone, including
decreased volume of mineralized bone volume and
decreased proportion of osteoblast-covered bone [7].
In the peri-operative group, there was no observed dif-
ference in bone mineralization, which concurs with previ-
ous work by Erhart et al. [7]. The power of these
observations was however low, and this may represent a
Type II error. The high power of the equivalent observa-
tions in the preoperative group is highly suggestive of a real
effect, and the difference between groups may be spurious.
Of interest in the peri-operative group are the major
differences in energy at yield and yield strain with differ-
ence in means of 30 % (energy at yield) and 29 % (yield
strain) and appropriate statistical power. This is suggestive
of a real effect and may have clinical implications, par-
ticularly because the main concern in human practice is of
regenerate failure after fixator removal. The reduction in
energy at yield after cytotoxic chemotherapy is likely to be
clinically important and if translated into human practice
may represent an increased risk of regenerate failure after
limb reconstruction. This may require either prolonged
fixator wear or external support after fixator removal;
however, further research is required to quantify this.
Definition of a chemotherapy regimen that would have a
clinically irrelevant effect on the material properties of the
regenerate is beyond the scope of this experiment.
It has been possible to develop a reproducible model of
limb lengthening in this species. Bone is consistently
formed in the distraction gap, and the overall alignment
was satisfactory in all lengthened limbs. This model is
suitable for future experiments investigating limb length-
ening in the juvenile New Zealand white rabbit. We have
observed that cytotoxic chemotherapy has a detrimental
affect on bone formed in a lapine model of distraction
osteogenesis. This should add a note of caution to the use
of this technique for reconstruction in a clinical context,
but this study is unable to address the effect of conven-
tional chemotherapy regimens in human subjects.
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